Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/28/07
End: 08/31/07
Due: 08/31/08
Phase: N/A
Priority: Normal
Start: 05/31/06
End: 10/31/06
Due: 10/31/07
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| ELB245 for 12 Weeks Versus 4mg Tolterodine in Patients With Incontinent Overactive Bladder (OAB) | NCT00439192 | elbion AG | user2@example.com | None | 2007-02-28 | 2007-08-31 | 2008-08-31 | - | - | 2025-07-14 |
| ELB139 Given Orally to Patients With Concurrent Panic Disorder, Challenged by CO2 Inhalation After a Single Dose and One Week of Treatment | NCT00322803 | elbion AG | user2@example.com | None | 2006-05-31 | 2006-10-31 | 2007-10-31 | - | - | 2025-07-14 |